Cyclic Adenosine Monophoshate by Radio
510(k) K823504
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK823504 | Date28 Jan 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CHO
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1230
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
This device is a radioimmunoassay system for cyclic AMP, classified under the FDA’s product code CHO (Clinical Chemistry). It measures adenosine 3′,5′-monophosphate (cyclic AMP) levels in biological samples, including plasma, urine, and other body fluids. Cyclic AMP assays are used to aid in the diagnosis of endocrine disorders, such as hyperparathyroidism, by quantifying hormone-related signaling molecules. The system relies on radiolabelled immunoassay techniques to achieve precise detection and quantification of cyclic AMP concentrations.
The device is supplied as a traditionally cleared 510(k) submission (K823504) under the FDA’s Clinical Chemistry advisory committee (CH). It is intended for in vitro diagnostic use and falls under Class II regulatory classification (862.1230). No information regarding sterility, single-use, or MRI safety is provided in the specifications. Storage conditions and reusability are not detailed in the available data, though it is classified as a radioimmunoassay kit requiring proper handling of radioactive materials. The submission was filed in 1982 and cleared in 1983.
Other devices from Immuno Nuclear Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the Cyclic AMP Radioimmunoassay Kit used for?
This kit is designed for in vitro diagnostic use to measure adenosine 3′,5′-monophosphate (cyclic AMP) levels in biological samples such as plasma, urine, and other body fluids. It aids in diagnosing endocrine disorders, including hyperparathyroidism, by quantifying hormone-related signaling molecules through radiolabelled immunoassay techniques.
How is the Cyclic AMP Radioimmunoassay Kit supplied?
The kit is supplied as a radioimmunoassay system, requiring proper handling of radioactive materials. It is intended for laboratory use and is classified under the FDA’s Clinical Chemistry product code (CHO). No specific details on sterility, single-use, or storage conditions are provided in the available data.
Is the Cyclic AMP Radioimmunoassay Kit single-use or reusable?
The available data does not specify whether the kit is single-use or reusable. However, as a radioimmunoassay system, it likely requires careful handling and may not be designed for repeated use due to the nature of radioactive materials involved.
What regulatory approval does the Cyclic AMP Radioimmunoassay Kit hold?
The kit holds a traditional 510(k) clearance (K823504) from the FDA, filed under the Clinical Chemistry advisory committee (CH) in 1982 and cleared in 1983. It is classified under the FDA’s product code CHO and falls under Class II regulatory classification (862.1230).
What types of biological samples can be tested with this kit?
The kit is specifically designed to measure cyclic AMP levels in plasma, urine, and other body fluids. It uses radiolabelled immunoassay techniques to provide precise detection and quantification of cyclic AMP concentrations in these samples.